Table 4. Mean difference and mean squared difference of full cohort and restricted cohort 5- and 10-year relative survival from period 5- and 10-year relative survival computed on 5-year calendar periods, respectively.
| 5-year relative survivala | 10-year relative survivala | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| |
Change from |
Full cohort |
Restricted Cohort |
Change from |
Full cohort |
Restricted Cohort |
||||
| Cancer | 1954–58 to 1999–03 | MD | MSD | MD | MSD | 1954–58 to 1994–98 | MD | MSD | MD | MSD |
| Oral cavity |
−1.9 |
−0.32 |
3.45 |
−0.41 |
4.34 |
−7.9 |
−0.68 |
2.98 |
−0.79 |
5.29 |
| Pancreas |
2.3 |
−0.07 |
0.08 |
0.06 |
0.21 |
0.2 |
−0.12 |
0.22 |
0.03 |
0.32 |
| Gallbladder |
6.9 |
−0.41 |
0.8 |
−0.05 |
2.41 |
5.9 |
0.17 |
0.88 |
0.81 |
2.91 |
| Liver |
7.4 |
−0.03 |
0.15 |
0.38 |
0.49 |
2.6 |
−0.01 |
0.19 |
0.29 |
0.41 |
| Trachea, lung and bronchus |
7.4 |
−0.16 |
0.23 |
0.24 |
0.18 |
4.7 |
−0.38 |
0.38 |
0.17 |
0.3 |
| Oesophagus |
8.7 |
−0.27 |
0.20 |
0.23 |
0.41 |
7.0 |
−0.45 |
0.80 |
0.29 |
1.44 |
| Brain & nervous system |
13.1 |
−0.23 |
1.44 |
0.44 |
1.78 |
10.3 |
0.57 |
1.18 |
1.64 |
3.86 |
| Cervix |
19.8 |
−0.01 |
4.09 |
1.03 |
14.22 |
9.3 |
−1.30 |
18.74 |
0.40 |
37.00 |
| Stomach |
20.1 |
−0.63 |
0.66 |
0.53 |
1.25 |
17.8 |
−1.64 |
3.1 |
0.87 |
1.04 |
| Larynx |
21.5 |
−0.46 |
6.08 |
0.60 |
9.29 |
17.2 |
−1.65 |
14.31 |
0.73 |
17.69 |
| Ovarian |
22.2 |
−1.06 |
2.61 |
0.09 |
2.02 |
10.1 |
−1.18 |
2.17 |
0.02 |
3.65 |
| Multiple myeloma |
27.8 |
−1.17 |
2.77 |
0.15 |
2.34 |
12.1 |
−1.20 |
11.89 |
0.21 |
9.3 |
| Leukaemias |
34.8 |
−0.27 |
1.24 |
1.49 |
4.26 |
23.0 |
−1.33 |
7.25 |
1.26 |
10.51 |
| Corpus uteri |
36.3 |
−0.46 |
1.57 |
1.31 |
3.78 |
37.8 |
−1.52 |
13.38 |
2.03 |
24.71 |
| Colorectal |
38.2 |
−0.81 |
1.09 |
1.10 |
1.61 |
33.8 |
−2.16 |
5.17 |
1.51 |
2.89 |
| Female breast |
38.2 |
−0.32 |
1.33 |
1.56 |
5.64 |
37.8 |
−0.52 |
4.17 |
3.24 |
18.71 |
| Non-Hodgkin lymphoma |
38.3 |
−1.13 |
10.18 |
0.69 |
8.89 |
27.6 |
−1.40 |
8.66 |
0.81 |
9.02 |
| Thyroid |
43.5 |
−0.95 |
2.87 |
1.24 |
5.47 |
48.9 |
−1.01 |
10.89 |
4.15 |
38.73 |
| Kidney |
44.2 |
−0.78 |
1.04 |
1.40 |
2.68 |
33.4 |
−2.10 |
5.67 |
1.83 |
7.08 |
| Skin melanoma |
45.8 |
−0.00 |
5.48 |
2.09 |
11.48 |
34.4 |
−0.73 |
47.49 |
3.52 |
61.67 |
| Bladder |
49.2 |
−0.63 |
3.69 |
1.78 |
6.50 |
46.6 |
−2.73 |
22.56 |
2.12 |
21.86 |
| Hodgkin lymphoma |
55.4 |
−1.07 |
4.9 |
1.96 |
6.64 |
38.9 |
−2.63 |
13.47 |
2.53 |
19.89 |
| Prostate | 64.3 | −0.55 | 5.3 | 2.31 | 16.90 | 48.7 | 0.28 | 17.66 | 4.44 | 80.07 |
Abbreviations: MD=mean difference; MSD=mean squared difference.
Finnish Cancer Registry, 23 most common forms of cancer in 1954–2003.
a
All survival estimates were age-adjusted to the International Standard Cancer Populations proposed by Corazziari et al (2004).